Covid-19: Covovax gets nod from drug regulator’s panel for emergency use in 12-17 yrs age group

2 views | Mar 05, 2022, 11:49:51 AM | Mirror Now
  • Share
Serum Institute of India's Covovax gets nod from the drug regulator's expert committee on Covid vaccines has recommended emergency use authorisation (EUA) in the age group of 12-17 years. However, it is yet to get final approval from Drugs Controller General of India (DCGI). Once approved by the regulator, Covovax will become the fourth vaccine approved for adolescents of 12-17 years age.

Short Videos